CNY 31.8
(-0.31%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 625.46 Million CNY | -22.25% |
2022 | 804.41 Million CNY | 20.93% |
2021 | 665.17 Million CNY | -26.66% |
2020 | 906.92 Million CNY | -10.22% |
2019 | 1.01 Billion CNY | 92.52% |
2018 | 524.67 Million CNY | 90.15% |
2017 | 275.92 Million CNY | -6.92% |
2016 | 296.44 Million CNY | -19.78% |
2015 | 369.52 Million CNY | -10.63% |
2014 | 413.48 Million CNY | 58.62% |
2013 | 260.67 Million CNY | -3.31% |
2012 | 269.59 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 787.3 Million CNY | 25.88% |
2024 Q2 | 992.57 Million CNY | 26.07% |
2024 Q3 | 1.03 Billion CNY | 4.38% |
2023 Q1 | 762.78 Million CNY | -5.17% |
2023 Q3 | 654.08 Million CNY | -5.57% |
2023 Q4 | 625.46 Million CNY | -4.38% |
2023 FY | 625.46 Million CNY | -22.25% |
2023 Q2 | 692.69 Million CNY | -9.19% |
2022 Q4 | 804.41 Million CNY | 15.9% |
2022 Q3 | 694.06 Million CNY | -3.15% |
2022 Q2 | 716.62 Million CNY | 25.25% |
2022 Q1 | 572.13 Million CNY | -13.99% |
2022 FY | 804.41 Million CNY | 20.93% |
2021 Q2 | 627.4 Million CNY | -17.4% |
2021 Q1 | 759.53 Million CNY | -16.25% |
2021 Q4 | 665.17 Million CNY | 20.34% |
2021 Q3 | 552.73 Million CNY | -11.9% |
2021 FY | 665.17 Million CNY | -26.66% |
2020 Q1 | 1.13 Billion CNY | 12.54% |
2020 FY | 906.92 Million CNY | -10.22% |
2020 Q3 | 969.48 Million CNY | -15.7% |
2020 Q4 | 906.92 Million CNY | -6.45% |
2020 Q2 | 1.15 Billion CNY | 1.17% |
2019 Q4 | 1.01 Billion CNY | 15.04% |
2019 FY | 1.01 Billion CNY | 92.52% |
2019 Q2 | 756.2 Million CNY | 63.76% |
2019 Q3 | 878.04 Million CNY | 16.11% |
2019 Q1 | 461.76 Million CNY | -11.99% |
2018 FY | 524.67 Million CNY | 90.15% |
2018 Q1 | 241.99 Million CNY | -12.3% |
2018 Q4 | 524.67 Million CNY | 20.66% |
2018 Q3 | 434.81 Million CNY | 39.87% |
2018 Q2 | 310.86 Million CNY | 28.46% |
2017 Q2 | 281.04 Million CNY | 6.88% |
2017 Q3 | 342.7 Million CNY | 21.94% |
2017 FY | 275.92 Million CNY | -6.92% |
2017 Q1 | 262.93 Million CNY | -11.3% |
2017 Q4 | 275.92 Million CNY | -19.49% |
2016 Q1 | - CNY | 0.0% |
2016 Q4 | 296.44 Million CNY | -3.93% |
2016 FY | 296.44 Million CNY | -19.78% |
2016 Q3 | 308.55 Million CNY | 0.0% |
2015 FY | 369.52 Million CNY | -10.63% |
2015 Q1 | 339.45 Million CNY | 0.0% |
2014 FY | 413.48 Million CNY | 58.62% |
2013 FY | 260.67 Million CNY | -3.31% |
2012 FY | 269.59 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Shanghai Kinetic Medical Co., Ltd | 398.21 Million CNY | -57.066% |
Double Medical Technology Inc. | 1.42 Billion CNY | 56.229% |
Sinocare Inc. | 2.45 Billion CNY | 74.536% |
Tellgen Corporation | 144.04 Million CNY | -334.209% |